BUNITROLOL

Bunitrolol is a non‑selective beta‑blocker that reduces heart rate and myocardial oxygen demand. Used for hypertension and arrhythmias, it stabilizes cardiac function. Side effects include fatigue, dizziness, bradycardia, and potential bronchoconstriction in sensitive individuals.

SKU: b1b751d32f8c Category: Tag:

Product Description


Mechanism of action

Bunitrolol is a non-selective β-adrenergic receptor antagonist with intrinsic sympathomimetic activity (ISA). It blocks β₁ and β₂ receptors while simultaneously providing partial agonist effects, resulting in reduced heart rate and contractility with less resting bradycardia than pure antagonists.

Benefits and advantages

Used in β-receptor pharmacology, ISA-mechanism studies, cardiovascular research, arrhythmia modelling, β-antagonist SAR analysis and receptor-selectivity comparisons.

Side effects and risks

Risks include bronchoconstriction, fatigue, dizziness, bradycardia and metabolic effects. Handle using beta-blocker safety controls.

Datasheet


Molecular Formula

C12H16N2O3

Molecular Weight

248.32 g/mol

CAS Number

34915-68-9

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Bunitrolol; 34915-68-9; Bunitrololum; KO-1366; F2613LO055

IUPAC/Chemical Name

2-[3-(tert-butylamino)-2-hydroxypropoxy]benzonitrile

InChl Key

VCVQSRCYSKKPBA-UHFFFAOYSA-N

InChl Code

InChI=1S/C14H20N2O2/c1-14(2,3)16-9-12(17)10-18-13-7-5-4-6-11(13)8-15/h4-7,12,16-17H,9-10H2,1-3H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/2473;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download